Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil-CVP for AIDS-Related Systemic Lymphoma
NCT00003388Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jul 1999
- Primary completion
- Apr 2003
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in AIDS-related lymphoma, sponsored by Eastern Cooperative Oncology Group. Started Jul 1999; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
AIDS-related lymphoma
Beyond the preview
Go deeper on NCT00003388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003388.